Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prisun Pharmatech is a China-based pharmaceutical technology company specializing in the design, synthesis, process development, pilot/commercial production, and sales of small molecule drug building blocks and key intermediates. It offers comprehensive services including R&D, manufacturing, import/export of APIs/intermediates/excipients/impurities/packaging materials/lab instruments/pharma machinery. The company acts as both a CDMO for custom synthesis projects and an international distributor/representative for pharma products. No proprietary clinical results or programs are reported.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prisun Pharmatech.